Clinical Study Site 213 — El Dorado, Kansas

Clinical Study Site 213 is a clinical research site located in El Dorado, Kansas, United States 67042.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Clinical Study Site 213 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Obesity, Overweight, Weight Maintenance.

Sponsors: Verdiva Bio Dev Limited.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in El Dorado

Browse all research sites in Kansas · View every site in El Dorado

• Susan B. Allen Memorial Hospital
• Cancer Center of Kansas - El Dorado
• Cancer Center of Kansas, PA - El Dorado
• Cancer Center of Kansas, P.A. - El Dorado
• Alliance for Multispecialty Research, LLC
• GSK Investigational Site
• AMR El Dorado
• Research Site
• AMR Clinical
• Alliance for Multispecialty Research -El Dorado
• Heartland Research Associates, an AMR Company
• AMR Clinical, El Dorado

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Study Site 213?

Clinical Study Site 213 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Study Site 213 conducted?

Clinical Study Site 213 has 1 clinical trials on record, with 1 currently active. Their work covers Obesity, Overweight, Weight Maintenance.

Is Clinical Study Site 213 accredited by Crixeo Clinical Trials?

Clinical Study Site 213 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Study Site 213?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.